Missouri 2024 Regular Session

Missouri Senate Bill SB978

Introduced
1/3/24  

Caption

Enacts provisions relating to payments for prescription drugs

Impact

The implementation of SB978 has significant implications for state laws regarding healthcare reimbursement. It specifically amends chapter 376 of the Revised Statutes of Missouri, establishing that health carriers and pharmacy benefits managers must treat covered entities equivalently to other similar pharmacies. Violating these provisions can result in civil penalties, up to five thousand dollars per violation per day. This regulation aims to enhance fair market practices and ensure that the intended benefits of the 340B program reach the underserved populations that these entities serve.

Summary

Senate Bill 978 aims to address discrimination against certain healthcare providers, specifically those classified as 'covered entities' under the federal 340B Drug Pricing Program. The bill introduces provisions that restrict health carriers and pharmacy benefits managers from imposing unfavorable conditions or reimbursement rates on covered entities. By preventing discriminatory practices, SB978 seeks to ensure that covered entities can dispense 340B drugs without facing penalties or barriers that would disadvantage them compared to other pharmacies.

Sentiment

The sentiment around SB978 appears to be supportive among advocates for healthcare equality and access. Proponents argue that the bill is essential in protecting the interests of covered entities, ensuring they are not unfairly treated and allowing them to serve vulnerable populations effectively. However, there might be apprehensions from some health carriers and pharmacy benefit managers regarding the financial implications of stricter regulations, suggesting a mixed response from industry stakeholders.

Contention

While the bill enjoys support for its overarching goal of equity in drug pricing, contention may arise around how it could impact the operational flexibility of health carriers and pharmacy benefits managers. Critics may argue that imposing strict regulations could complicate their operations or increase costs associated with compliance. Additionally, questions may be raised about the implementation and enforcement of penalties, as they could impose significant burdens on these organizations. Overall, the tension between protecting access to affordable medications and the operational concerns of insurers remains a focal point of debate.

Companion Bills

No companion bills found.

Similar Bills

CA AB913

Pharmacy benefit managers.

CA SB362

Chain community pharmacies: quotas.

LA HB432

Provides for the regulation of pharmacy services administrative organizations (OR +$88,000 SG EX See Note)

MS HB1125

Pharmacy services; prohibit insurers and PBMs from requiring persons to obtain exclusively through pharmacies that they own.

LA HB387

Provides for the regulation of pharmacy services administrative organizations

CA AB401

Pharmacy: remote dispensing site pharmacy: telepharmacy: shared clinic office space.

CA AB690

Pharmacies: relocation: remote dispensing site pharmacy: pharmacy technician: qualifications.

AR SB593

To Amend The Arkansas Pharmacy Benefits Manager Licensure Act; And To Create The Pharmacy Services Administrative Organization Act.